Welcome!

Open Source Authors: Patrick Burke, Jeremy Geelan, Maureen O'Gara, Pat Romanski, Tony Baer

Related Topics: Open Source

Open Source: Article

Nathan Myhrvold Part of Transmeta Sale

Both Intel and AMD have licensed Transmeta's widgetry

Nathan Myhrvold's Intellectual Ventures (IV), the great patent vacuum, has a piece of Novafora's deal to buy Transmeta, according to a filing dropped off with the SEC.

IV was apparently there at the bargaining table with Novafora, which makes digital video processors. It's putting $11.6 million towards the $255.6 million purchase price in exchange for some kind of rights to Transmeta's low-power silicon patents, perhaps so IV can protect one of its investors.

Remember now that $255.6 mil is about what Transmeta has in the bank and both Intel and AMD have licensed Transmeta's widgetry.

More Stories By Maureen O'Gara

Maureen O'Gara the most read technology reporter for the past 20 years, is the Cloud Computing and Virtualization News Desk editor of SYS-CON Media. She is the publisher of famous "Billygrams" and the editor-in-chief of "Client/Server News" for more than a decade. One of the most respected technology reporters in the business, Maureen can be reached by email at maureen(at)sys-con.com or paperboy(at)g2news.com, and by phone at 516 759-7025. Twitter: @MaureenOGara

Comments (1) View Comments

Share your thoughts on this story.

Add your comment
You must be signed in to add a comment. Sign-in | Register

In accordance with our Comment Policy, we encourage comments that are on topic, relevant and to-the-point. We will remove comments that include profanity, personal attacks, racial slurs, threats of violence, or other inappropriate material that violates our Terms and Conditions, and will block users who make repeated violations. We ask all readers to expect diversity of opinion and to treat one another with dignity and respect.


Most Recent Comments
rzcashman 12/01/08 05:40:40 PM EST

I'll be the first one to cry foul once someone does something wrong with the patent system, but as things stand, I have to object to the tone of your calling IV a "patent vacuum" along with any implications of wrongdoing just because they had a strong part in the Transmeta transaction. Transmeta has many patents, and there was nothing other than good business sense for them to be at the table. If you or I had the opportunity to be in their shoes, there is no denying that we would have certainly been there too. If you object to their size, their vast patent holdings, and/or the power and responsibility that they wield, that is a separate issue.